What enzyme deficiency is likely responsible for the conversion of 17-hydroxyprogesterone to 11-deoxycortisol in a newborn with congenital adrenal hyperplasia (CAH) and electrolyte imbalance?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

21-Hydroxylase Deficiency in a Newborn with Congenital Adrenal Hyperplasia

The newborn is most likely deficient in 21-hydroxylase (CYP21A2), which is responsible for converting 17-hydroxyprogesterone to 11-deoxycortisol in the cortisol synthesis pathway.

Clinical Presentation Analysis

The clinical presentation strongly indicates congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency:

  • Virilization in a female infant: Clitoral enlargement and labioscrotal fusion in a 46,XX karyotype infant 1
  • Electrolyte abnormalities: Hypernatremia (151 mg/dL) and hypokalemia (3.2 mg/dL) 1
  • Hypertension: Blood pressure of 142/85 mm Hg in a newborn 1

Pathophysiology of 21-Hydroxylase Deficiency

21-hydroxylase deficiency accounts for more than 90% of CAH cases 2. This enzyme deficiency results in:

  1. Cortisol synthesis blockade: The enzyme normally converts 17-hydroxyprogesterone to 11-deoxycortisol in the glucocorticoid pathway 3
  2. Mineralocorticoid pathway disruption: Also blocks conversion of progesterone to deoxycorticosterone 3
  3. Androgen excess: Precursors are diverted to sex hormone biosynthesis, causing virilization 2

Biochemical Confirmation

The biochemical hallmark of 21-hydroxylase deficiency is:

  • Elevated 17-hydroxyprogesterone: The substrate accumulates due to the enzyme block 4
  • Elevated 21-deoxycortisol: Some accumulated 17-hydroxyprogesterone is converted to 21-deoxycortisol by 11β-hydroxylase, making it a specific marker for 21-hydroxylase deficiency 4, 5

Differential Diagnosis

While the presentation strongly suggests 21-hydroxylase deficiency, other enzyme deficiencies in CAH should be considered:

  • 11β-hydroxylase deficiency: Can present with hypertension and hypokalemia but would show elevated 11-deoxycortisol and deoxycorticosterone 1
  • 17α-hydroxylase deficiency: Would present with incomplete masculinization in males and primary amenorrhea in females, not virilization 1

Conclusion

The combination of virilization in a female infant with 46,XX karyotype, hypertension, hypernatremia, and hypokalemia is classic for 21-hydroxylase deficiency. This enzyme is critical for converting 17-hydroxyprogesterone to 11-deoxycortisol in the cortisol synthesis pathway, and its deficiency leads to the clinical and biochemical manifestations observed in this newborn.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.